HDAC Inhibitors Finally Open Up: Chromatin Accessibility Signatures of CTCL.
Cancer Cell
Authors | |
Keywords | |
Abstract | In this issue of Cancer Cell, Qu et al. describe the chromatin accessibility profiles of cutaneous T cell lymphoma, with dynamic assessments of response and resistance to histone deacetylase inhibitor therapy. Their "personal regulome" analysis framework reveals chromatin features that may be predictive of clinical response to epigenetic therapy. |
Year of Publication | 2017
|
Journal | Cancer Cell
|
Volume | 32
|
Issue | 1
|
Pages | 1-3
|
Date Published | 2017 07 10
|
ISSN | 1878-3686
|
DOI | 10.1016/j.ccell.2017.06.008
|
PubMed ID | 28697338
|
Links | |
Grant list | K99 CA190861 / CA / NCI NIH HHS / United States
|